Table 1. Characteristics of included studies on closed pleural biopsy.
Author [year] | Country/region | Number of centres |
Type of study | No. of patients | Inclusion criteria | Q score | TP | FP | FN | TN | No. of complications |
---|---|---|---|---|---|---|---|---|---|---|---|
Nusair et al. [2002] | Israel | Unicentric | Retrospective | 44 | Patients with an exudative pleural effusion with no accompanying pleural or subpleural thickening ormass | 5 | 13 | 0 | 10 | 19 | 3 |
Al-Shimemeri et al. [2003] | Saudi Arabia | Unicentric | Retrospective | 110 | Patients with an exudative pleural effusion | 6 | 54 | 0 | 32 | 24 | 4 |
Maskell et al. [2003] | UK | Unicentric | RCT | 25 | Patients with cytologically negative suspected malignant pleural effusions | 7 | 15 | 0 | 9 | 1 | 1 |
Botana-Rial et al. [2013] | Spain | Unicentric | Prospective | 67 | Patients with an exudative pleural effusion | 4 | 48 | 0 | 6 | 13 | 1 |
Jakubec et al. [2014] | Olomouc | Unicentric | Prospective | 222 | Patients with pleural effusion and cytologic examination of pleural fluid was negative | 7 | 99 | 0 | 58 | 65 | 22 |
Devkota et al. [2014] | Nepal | Unicentric | Prospective | 47 | Patients with an exudative pleural effusion | 6 | 28 | 0 | 3 | 16 | – |
Maturu et al. [2015] | India | Unicentric | Retrospective | 84 | Patients with exudative pleural effusions and remain undiagnosed after thoracentesis | 7 | 63 | 0 | 13 | 8 | 7 |
Báez-Saldaña et al. [2017] | México | Unicentric | Prospective | 863 | Diagnosing malignancy in patients with pleural effusion | 5 | 450 | 5 | 137 | 271 | 38 |
Zuberi et al. [2016] | Pakistan | Multicentric | Prospective | 94 | Patients with an exudative pleural effusion | 7 | 74 | 0 | 2 | 20 | – |
Rajawat et al. [2017] | India | Unicentric | Retrospective | 191 | Patients with exudative lymphocytic pleural effusion | 4 | 123 | 0 | 13 | 55 | – |
TP, true positive; FP, false positive; FN, false negative; TN, true negative; RCT, randomized controlled trial.